<DOC>
	<DOCNO>NCT01568281</DOCNO>
	<brief_summary>This study investigate whether anastrozole ODF bioequivalent Arimidex tablet single oral administration anastrozole formulation .</brief_summary>
	<brief_title>Bioequivalence Study Comparing Arimidex Tablet Anastrozole ODF Japanese Healthy Male Subjects</brief_title>
	<detailed_description>A Randomised , Open label , Single centre , 2 way Crossover Bioequivalence Study Comparing Arimidex Tablet 1 mg Anastrozole Orally Rapid Disintegration Film Formula 1 mg After Single Oral Administration Japanese Healthy Male Subjects</detailed_description>
	<mesh_term>Anastrozole</mesh_term>
	<criteria>Provision sign date , write informed consent prior study specific procedures Japanese healthy male subject age 20 45 year Male subject willing use barrier contraception ie , condom , 3 month last dose investigational product Have body mass index ( BMI ) 18 27 kg/m2 History clinically significant disease disorder History presence gastrointestinal , hepatic renal disease condition know interfere absorption , distribution , metabolism excretion drug Any clinically significant illness , medical/surgical procedure trauma Any clinically significant abnormality clinical chemistry , haematology urinalysis result</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>safety</keyword>
	<keyword>anastrozole</keyword>
	<keyword>Arimidex</keyword>
	<keyword>Japanese</keyword>
	<keyword>healthy subject</keyword>
</DOC>